Hui Tian, Ph.D.

Director of Research

Dr. Tian joined NGM Biopharmaceuticals as the Director of Research in January 2008, providing leadership for the company's discovery research efforts. He was most recently the Scientific Director in the Metabolic Disorders Therapeutic Area at Amgen, responsible for early stage discovery research in the area of diabetes and lipid disorders. Prior to Amgen, he was responsible for the orphan G protein-coupled receptor drug discovery program at Tularik, successfully leading several projects in multiple therapeutic areas, including metabolic disease, inflammation, and neurodegenerative disorders. During the course of these efforts, Dr. Tian and his team identified several clinical candidates for study in humans.